The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia

Blood

Volumn 111, Issue 6, 2008, Pages 3225-3228

  Duhamel, Marianne ^a   Arrouss, Issam ^a   Merle Béral, Hélène ^b,c   Rebollo, Angelita ^a  

^a Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AIOLOS TRANSCRIPTION FACTOR; IKAROS TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; IKZF3 PROTEIN, HUMAN; ISOPROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; UPREGULATION; AGED; B CELL LEUKEMIA; B LYMPHOCYTE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MIDDLE AGED; PROMOTER REGION;

AGED; B-LYMPHOCYTES; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 42449161940     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-09-113191     Document Type: Article

References (26)

1. Chiorazzi N, Hatzi K. Albesiano E. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann N YAcad Sci. 2005;1062:1-12.
2. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251-262.
3. Morgan B, Sun L, Avitahl N, et al. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 1997;16:2004-2013.
4. Wang JH, Avitahl N, Gariappa A, et al. Aiolos regulates B cell activation and maturation to effector state. Immunity. 1998;9:543-553.
5. Kirn J, Sif S, Jones B, et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity. 1999;10: 345-355.
6. Caballero R, Setien F, Lopez-Serra L, et al. Combinatorial effects of splice variants modulate function of Aiolos. J Cell Sci. 2007;120:2619-2630.
7. Navarro P, Page DR, Avner P, Rougeulle C. Tsixmediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program. Genes Dev. 2006;20:2787-2792.
8. GhadiriA, Duhamel M, Fleischer A, Reimann A, Dessauge F. Rebollo A. Critical function of Ikaros in controlling Aiolos gene expression. FEBS Lett. 2007;581:1605-1616.
9. Liippo J. Nera KP, Veistinen E. et al. Both normal and leukemic B lymphocytes express multiple isoforms of the human Aiolos gene. Eur J Immunol. 2001;31:3469-3474.
10. Nakayama H, Ishimaru F, Avitahl N, et al. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res. 1999;59:3931-3934.
11. Tonnelle C, Imbert MC, Sainty D, Granjeaud S, N'Guyen C, Chabannon C. Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigen. Hematol J. 2003;4:104-109.
12. Yagi T. Hibi S, Takanashi M. et al. High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis. Blood. 2002;99:1350-1355.
13. Romero F, Martinez AC, Camonis J, Rebollo A. Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. EMBO J. 1999;18:3419-3430.
14. Narvi E, Nera KP, Terho P, Mustonen L, Granberg J, Lassila O. Aiolos controls gene conversion and cell death in DT40 B cells. Scand J Immunol. 2007;65:503-513.
15. Hanada M, Delia D, Aiello A. Stadtmauer E, Reed JC. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood. 1993;82:1820-1828.
16. Calin GA, Ferracin M, Cimmino A, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353:1793-1801.
17. Cimmino A, Calin GA. Fabbri M. et al. miR-15and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944-13949.
18. Allsup DJ, Kamiguti AS, Lin K, et al. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia. Cancer Res. 2005;65:7328-7337.
19. Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F. Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 2003;101:1087-1093.
20. Raval A, Byrd JC, Plass C. Epigenetics in chronic lymphocytic leukemia. Semin Oncol. 2006;33: 157-166.
21. Nera KP, Kohonen P, Narvi E, et al. Loss of Pax5 promotes plasma cell differentiation. Immunity. 2006;24:283-293.
22. Thompson EC, Cobb BS, Sabbattini P, et al. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity. 2007;26:335-344.
23. Ferrer A, Ollila J, Tobin G, et al. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2004;153:69-72.
24. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol. 2002;2:162-174.
25. Duhamel M, Navarro P, Cario-André M, Billot K, Arrouss I, Rebollo A. Differential epigenetic regulation of Aiolos expression in human tumoral cell lines and primary cells. FEBS Lett. 2008;582:457-467.
26. Pokholok DK, Harbison CT, Levine S, et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell. 2005;122:517-527.